DNA vaccines for prophylactic or therapeutic immunization against hepatitis B virus

Mount Sinai Journal of Medicine

Volumn 66, Issue 2, 1999, Pages 84-90

  Davis, Heather L ^a,b,c  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Antibody; Cytotoxic T lymphocyte; DNA vaccine; Hepatitis B; Immunotherapy

Indexed keywords

DNA VACCINE;

ARTICLE; CELLULAR IMMUNITY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNIZATION; PROPHYLAXIS;

ANIMALS; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; VACCINATION; VACCINES, DNA;

EID: 0032977643     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Guidotti LG, Ando K, Hobbs MV, et al. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc Natl Acad Sci USA 1994; 91:3764-3768.
2. Guidotti LG, Ishikawa T, Hobbs MV, et al. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996; 4:25-36.
3. World Health Organization Programme for Vaccine Development. Potential use of live viral and bacterial vectors for vaccines. Vaccine 1990; 8:425-437.
4. Davis HL, Weeratna R, Waldschmidt TJ, et al. CpG DNA is a potent adjuvant in mice immunized with recombinant hepatitis B surface antigen. J Immunol 1998; 160:870-876.
5. Lanzavecchia A. Identifying strategies for immune intervention. Science 1993; 260:937-944.
6. Davis HL, Mancini M, Michel ML, Whalen RG. DNA-mediated immunization to hepatitis B surface antigen: Longevity of primary response and effect of boost. Vaccine 1996; 14:910-915.
7. Davis HL. Plasmid DNA expression systems for the purpose of immunization. Curr Opin Biotechnol 1997; 8:635-646.
8. Donnelly JJ, Ulmer JB, Shiver JW, Liu MA. DNA vaccines. Annu Rev Immunol 1997; 15:617-648.
9. Davis HL. DNA-based vaccination against hepatitis B virus. Adv Drug Deliv 1996; 21:33-47.
10. Buendia MA. Hepatitis B viruses and hepatocellular carcinoma. Adv Cancer Res 1992; 59:167-226.
11. Davis HL, Michel ML, Whalen RG. DNA-based immunization for hepatitis B induces continuous secretion of antigen and high levels of circulating antibody. Hum Mol Genet 1993; 2:1847-1851.
12. Davis HL, Schirmbeck R, Reimann J, Whalen RG. DNA-mediated immunization in mice induces a potent MHC class-I restricted cytotoxic T lymphocyte response to the hepatitis B envelope protein. Hum Gene Ther 1995; 6:1447-1456.
13. Davis HL, McCluskie MJ, Gerin JL, Purcell RH. DNA vaccine for hepatitis B: Evidence for immunogenicity in chimpanzees and comparison with other vaccines. Proc Natl Acad Sci USA 1996; 93:7213-7218.
14. Prince AM, Whalen RG, Brotman B. Successful DNA-based HBV immunization of newborn chimpanzees. Vaccine 1997; 15:916-919.
15. Brazolot Millan CL, Weeratna R, Krieg AM, et al. CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice. Proc Natl Acad Sci USA 1998; 95:15553-15558.
16. Ulmer JB, Deck RR, DeWitt CM. Generation of MHC class-I restricted T lymphocytes by expression of a viral protein in muscle cells: Antigen presentation by non-muscle cells. Immunology 1996; 89:59-67.
17. Doe B, Selby S, Barnett J, et al. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc Natl Acad Sci USA 1996; 93:8578-8583.
18. Iwasaki A, Torres CA, Ohashi P, et al. The dominant role of bone-marrow derived cells in CTL induction following plasmid DNA immunization at different sites. J Immunol 1997; 159:11-14.
19. Corr M, Lee DJ, Carson DA, Tighe H. Gene vaccination with naked plasmid DNA: Mechanism of CTL priming. J Exp Med 1996; 184:1555-1560.
20. Torres CA, Iwasaki A, Barber BH, Robinson HL. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J Immunol 1997; 158:4529-4532.
21. Condon C, Watkins SC, Celluzzi CM, et al. DNA-based immunization by in vivo transfection of dendritic cells. Nat Med 1996; 2:1122-1128.
22. Klinman DM, Yi AK, Beaucage SL, et al. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12 and interferon. Proc Natl Acad Sci USA 1996; 93:2879-2883.
23. Krieg AM, Yi AK, Matson S, et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995; 374:546-549.
24. Klinman DM, Yamshchikov G, Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J Immunol 1997; 158:3635-3639.
25. Sato Y, Roman M, Tighe H, et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 1996; 273:352-354.
26. Krieg AM, Yi AK, Schorr J, Davis HL. The role of CpG dinucleotides in DNA vaccines. Trends Microbiol 1998; 6:23-27.
27. World Health Organization Expert Committee on Biological Standardization. Requirements for hepatitis B vaccine. Bull World Health Organ 1988; 66:443-455.
28. Kruskall MS, Alper CA, Awdeh Z, et al. The immune response to hepatitis B vaccine in humans: Inheritance patterns in families. J Exp Med 1992; 175:495-502.
29. Hervas-Stubbs S, Berasain C, Golvano JJ, et al. Overcoming class II-linked non-responsiveness to hepatitis B vaccine. Vaccine 1994; 12:867-871.
30. Alper CA, Kruskall MS, Marcus-Bagley D, et al. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med 1989; 321:708-712.
31. Rehermann B, Lau D, Hoofnagle JH, Chisari FV. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J Clin Invest 1997; 96:1655-1665.
32. Mancini M, Hadchouel M, Davis HL, et al. DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state. Proc Natl Acad Sci USA 1996; 93:12496-12501.
33. Chisari FV. Cytotoxic T cells and viral hepatitis. J Clin Invest 1997; 99:1472-1477.
34. Cavanaugh VJ, Guidotti LG, Chisari FV. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. J Virol 1997; 71:3236-3243.
35. Wolff JA, Ludtke JJ, Acsadi G, et al. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet 1992; 1:363-369.
36. Davis HL, Brazolot Millan CL, Watkins SC. Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA. Gene Ther 1997; 4:181-188.
37. Nichols WW, Ledwith BJ, Manam SV, Troilo PJ. Potential DNA vaccine integration into host cell genome. Ann NY Acad Sci 1995; 772:30-39.
38. Pisetsky DS. Immunostimulatory DNA: A clear and present danger? Nat Med 1997; 3:829-831.
39. Pisetsky DS. Immune activation by bacterial DNA: A new genetic code. Immunity 1996; 5:303-310.
40. Pisetsky DS. Immunologic consequences of nucleic acid therapy. Antisense Res Dev 1995; 5:219-225.
41. Wang R, Doolan DL, Le TP, et al. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 1998; 282:476-480.
42. Calarota S, Bratt G, Nordlund S, et al. Cellular cytotoxic response induced by DNA vaccination in HIV-1- infected patients. Lancet 1998; 351:1320-1325.
43. MacGregor RR, Boyer JD, Ugen KE, et al. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: Safety and host response. J Infect Dis 1998; 178:92-100.
44. Ugen KE, Nyland SB, Boyer JD, et al. DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans. Vaccine 1998; 16:1818-1821.
45. Sasaki S, Tsuji T, Hamajima K, et al. Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1. Infect Immun 1997; 65:3520-3528.
46. Kim JJ, Trivedi NN, Nottingham LK, et al. Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens. Eur J Immunol 1998; 28:1089-1103.
47. Iwasaki A, Stiernholm BJN, Chan AK, et al. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J Immunol 1997; 158:4591-4601.
48. Kim JJ, Bagarazzi ML, Trivedi N, et al. Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes. Nat Biotechnol 1997; 15:641-646.